Biden proposes weight loss drug coverage requirements for ... - NBC News
Nov 26, 2024 · The new rule, which was proposed by the administration Tuesday, would dramatically expand access to anti-obesity medications such as Ozempic and Wegovy, from Novo Nordisk, and Mounjaro and...
Do Anti-Obesity Medications Really Work? > News - Yale Medicine
Apr 2, 2024 · New anti-obesity medications, such as Wegovy, are being used to treat obesity as a disease. Yale Medicine experts tell you what you need to know.
Ozempic, Wegovy covered by Medicare and Medicaid under Biden ... - Fox News
Nov 26, 2024 · The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have Medicare and Medicaid.
Medicare, Medicaid: 7.4 million Americans could gain coverage for anti …
Nov 26, 2024 · Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal being unveiled Tuesday by the Biden administration.
Biden proposes Medicare and Medicaid cover weight-loss drugs | AP News
Nov 26, 2024 · Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning.
The Race for the Next Ozempic | WIRED
Jul 24, 2024 · Researchers are now racing to develop new anti-obesity medications that are more effective, more convenient, or produce fewer side effects than the ones currently on the market.
Science’s 2023 Breakthrough of the Year: Weight loss drugs
Dec 14, 2023 · Trials are underway for drug addiction, after people with obesity and diabetes described less longing for wine and cigarettes while on the treatment. Researchers theorize the drugs bind to receptors in the brain that mediate desire for other pleasures in addition to food.
Weight loss: Why people stick with Wegovy longer than older drugs
Dec 11, 2023 · New research shows that people are much more likely to adhere to newer semaglutide medications for long-term weight loss than older anti-obesity drugs. Semaglutides such as Wegovy, Ozempic,...
Weight-loss surgery down 25 percent as anti-obesity drug use …
Oct 28, 2024 · A new study examining a large sample of privately insured patients with obesity found that use of drugs such as Ozempic and Wegovy as anti-obesity medications more than doubled from 2022 to 2023. During that same period, there was a 25.6 percent decrease in patients undergoing metabolic bariatric surgery to treat obesity.
Beyond Ozempic: Trials Hold Promise of Highly Effective Obesity Drugs
Jun 30, 2023 · Semaglutide, also known by its brand names Ozempic and Wegovy, marks a new era in anti-obesity therapeutics. The unprecedented drug offers a safe and effective option for patients that addresses the root of obesity.